{
    "Trade/Device Name(s)": [
        "BD Phoenix Automated Microbiology System - Meropenem (0.125-32 \u03bcg/mL)"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K132674",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON",
        "JWY",
        "LRG",
        "LTT",
        "LTW"
    ],
    "Summary Letter Date": "December 27, 2013",
    "Summary Letter Received Date": "November 20, 2013",
    "Submission Date": "November 14, 2013",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Meropenem"
    ],
    "Specimen Type(s)": [
        "Pure culture isolates of Gram-negative aerobic and facultative anaerobic bacteria",
        "Pure culture isolates of Gram-positive bacteria"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix Automated Microbiology System"
    ],
    "Method(s)/Technology(ies)": [
        "Broth based microdilution test",
        "Redox indicator detection"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Minimal inhibitory concentration (MIC) determination"
    ],
    "Submission Type(s)": [
        "System",
        "Panel",
        "Instrument",
        "Software",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System panel with meropenem for antimicrobial susceptibility testing of Gram-negative and Gram-positive bacteria.",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration (MIC) of Gram-negative and Gram-positive bacteria isolates from pure culture, including Enterobacteriaceae, Non-Enterobacteriaceae, Staphylococcus, Enterococcus, and Streptococcus, using meropenem in Gram-negative ID/AST or AST panels.",
    "fda_folder": "Microbiology"
}